Therefore, xanthohumol may downregulate HK2 expression by inhibiting the activation of the EGFR/AKT pathway, thus affecting the glycolytic pathway and inducing apoptosis in CRC cells. The gene discussed is HK2; the disease is colorectal carcinoma.